Biotech | October 07, 2025
PromoCell launches custom GMP cell culture media to power next-gen cell and gene therapies
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Investment to expand manufacturing and global medicine supply capacity
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Marks first international filing for Evofem’s single-dose oral treatment
The NDA submission follows the successful completion of a pivotal Phase III global clinical trial
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
Takeda will seek an external partner to leverage its cell therapy platform technologies
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
Subscribe To Our Newsletter & Stay Updated
